Cargando…

Coexistence of Fabry disease with IgM nephropathy: A case report

RATIONALE: Coexistence of Fabry disease and IgM nephropathy is rare. The varying severity and unapparent clinical manifestation of Fabry disease makes it difficult to recognize when coexisting with another more prevalent cause of nephropathy requiring electron microscopy and genetic testing to confi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huizhen, Behera, Tapas Ranjan, Gong, Jianguang, Shen, Quanquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799670/
https://www.ncbi.nlm.nih.gov/pubmed/31593141
http://dx.doi.org/10.1097/MD.0000000000017566
_version_ 1783460337465425920
author Wu, Huizhen
Behera, Tapas Ranjan
Gong, Jianguang
Shen, Quanquan
author_facet Wu, Huizhen
Behera, Tapas Ranjan
Gong, Jianguang
Shen, Quanquan
author_sort Wu, Huizhen
collection PubMed
description RATIONALE: Coexistence of Fabry disease and IgM nephropathy is rare. The varying severity and unapparent clinical manifestation of Fabry disease makes it difficult to recognize when coexisting with another more prevalent cause of nephropathy requiring electron microscopy and genetic testing to confirm their coexistence. PATIENT CONCERNS: A 54-year-old female presented with proteinuria without any clinical signs or family history of Fabry disease. DIAGNOSES: Immunostaining of the renal biopsy identified mesangial IgM deposition diagnosing it as IgM nephropathy. The light microscopy indicated prominent vacuolization of podocytes. Further examination of toluidine blue stained semi-thin sections and electron microscopy revealed blue bodies and myelin bodies in the cytoplasm of podocytes, respectively. Mutation analysis detected missense mutation establishing the diagnosis of coexisting Fabry disease. INTERVENTIONS: The patient was treated with angiotensin-converting enzyme inhibitors. Enzyme replacement therapy was not administered due to financial constraints. OUTCOMES: After 2 months of treatment the patient demonstrated urine protein to creatinine ratio of 0.21 g/g. LESSONS: Identifying coexistence of Fabry disease with other nephropathy requires meticulous pathologic investigations including electron microscopy especially when Fabry disease presents with atypical phenotype.
format Online
Article
Text
id pubmed-6799670
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67996702019-11-18 Coexistence of Fabry disease with IgM nephropathy: A case report Wu, Huizhen Behera, Tapas Ranjan Gong, Jianguang Shen, Quanquan Medicine (Baltimore) 5200 RATIONALE: Coexistence of Fabry disease and IgM nephropathy is rare. The varying severity and unapparent clinical manifestation of Fabry disease makes it difficult to recognize when coexisting with another more prevalent cause of nephropathy requiring electron microscopy and genetic testing to confirm their coexistence. PATIENT CONCERNS: A 54-year-old female presented with proteinuria without any clinical signs or family history of Fabry disease. DIAGNOSES: Immunostaining of the renal biopsy identified mesangial IgM deposition diagnosing it as IgM nephropathy. The light microscopy indicated prominent vacuolization of podocytes. Further examination of toluidine blue stained semi-thin sections and electron microscopy revealed blue bodies and myelin bodies in the cytoplasm of podocytes, respectively. Mutation analysis detected missense mutation establishing the diagnosis of coexisting Fabry disease. INTERVENTIONS: The patient was treated with angiotensin-converting enzyme inhibitors. Enzyme replacement therapy was not administered due to financial constraints. OUTCOMES: After 2 months of treatment the patient demonstrated urine protein to creatinine ratio of 0.21 g/g. LESSONS: Identifying coexistence of Fabry disease with other nephropathy requires meticulous pathologic investigations including electron microscopy especially when Fabry disease presents with atypical phenotype. Wolters Kluwer Health 2019-10-11 /pmc/articles/PMC6799670/ /pubmed/31593141 http://dx.doi.org/10.1097/MD.0000000000017566 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5200
Wu, Huizhen
Behera, Tapas Ranjan
Gong, Jianguang
Shen, Quanquan
Coexistence of Fabry disease with IgM nephropathy: A case report
title Coexistence of Fabry disease with IgM nephropathy: A case report
title_full Coexistence of Fabry disease with IgM nephropathy: A case report
title_fullStr Coexistence of Fabry disease with IgM nephropathy: A case report
title_full_unstemmed Coexistence of Fabry disease with IgM nephropathy: A case report
title_short Coexistence of Fabry disease with IgM nephropathy: A case report
title_sort coexistence of fabry disease with igm nephropathy: a case report
topic 5200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799670/
https://www.ncbi.nlm.nih.gov/pubmed/31593141
http://dx.doi.org/10.1097/MD.0000000000017566
work_keys_str_mv AT wuhuizhen coexistenceoffabrydiseasewithigmnephropathyacasereport
AT beheratapasranjan coexistenceoffabrydiseasewithigmnephropathyacasereport
AT gongjianguang coexistenceoffabrydiseasewithigmnephropathyacasereport
AT shenquanquan coexistenceoffabrydiseasewithigmnephropathyacasereport